Investment for health and wellbeing

Q1 2025 published - read more

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q1 2025

Steady growth and progress towards long-term goals - outlook refined

Download report Download presentation Watch webcast recording

Annual Report 2024

Growth through strategy implementation. Find out more about Oriola's year 2024.

Go to Annual Report

Annual General Meeting 2025

Key resolutions from the AGM held on 2 April: A dividend of EUR 0.07 per share shall be paid for the financial year 2024. The AGM approved a shareholder's proposal to combine the company's A and B share classes after which the company will have only one single share class.

Q&A about the combination of share classes Read more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

29.04.2025 | Stock exchange releases

Oriola Corporation’s Interim Report January-March 2025
09.04.2025 | Stock exchange releases

Oriola publishes comparative information for new key financial indicators
07.04.2025 | Stock exchange releases

Oriola Corporation: Flagging notification in accordance with the Finnish Securities Market Act Chapter 9 § 5
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts